Saturday 17 October 2026 Export PCRX’s income statement to Excel — free account

Pacira BioSciences, Inc.

PCRX Healthcare Drug Manufacturers Specialty & Generic

Pacira BioSciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $726.4 million, up 3.63% from fiscal 2024. In the quarter to June 2026, revenue grew 6.24%, EPS grew 209.1%, free cash flow grew 502.5% and total debt fell 37.4%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

36.35 0.02 +0.06%

Follow PCRX

Alert me

Market cap: $1.5B
P/E: 104×
Fwd P/E: 33.7×
Dividend yield: —
F-score: 8/9
Altman Z: 2.02
Beneish M: −2.93
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	56.02	172.53	188.33	72.49
P/S ratio Full definition →		1.58	1.59	1.24	1.34
P/FCF ratio Full definition →		9.14	8.44	6.89	5.58
P/Operating CF Full definition →		18.66	26.40	35.61	17.42
P/B ratio Full definition →		1.56	1.66	1.40	1.49
Price to Tangible BV Full definition →		3.50	3.78	3.26	2.73
EV/Sales Full definition →		2.05	2.05	1.74	1.76
EV/EBITDA Full definition →		11.44	13.76	11.21	12.77
EV/Operating CF Full definition →		10.38	9.80	9.02	7.01
EV/FCF Full definition →		11.82	10.90	9.66	7.33
Quick Ratio Full definition →		3.38	3.01	3.01	3.14
Current Ratio Full definition →		5.26	4.54	4.73	5.04
Net Debt/EBITDA Full definition →		4.65	6.92	5.86	4.10
Debt/Assets Full definition →		29.03%	29.42%	30.42%	29.19%
Debt/Equity Full definition →		0.52	0.54	0.56	0.54
Asset Turnover Full definition →		0.51	0.52	0.53	0.54
Operating CF/Net income Full definition →		11.20	26.69	8.81	12.35
Capex/Depreciation Full definition →		(0.18)	(0.01)	(0.13)	(0.06)
Interest Coverage Full definition →		1.49	0.60	1.87	1.18
Research and Development Expense of Revenue Full definition →		14.46%	19.20%	15.83%	15.72%
Selling, General and Administrative Expense of Revenue Full definition →		51.14%	51.61%	52.96%	47.72%
Intangible Assets out of Total Assets Full definition →		0.31	0.31	0.31	0.25
Share Based Compensation of Revenue Full definition →		7.79%	6.86%	7.63%	7.77%
Graham Net Nets Full definition →		(0.01)	(0.02)	(0.04)	0.04
Graham Number Full definition →		13.07	7.25	6.61	11.58
Earnings Yield Full definition →		1.79%	0.58%	0.53%	1.38%
Free Cash Flow Yield Full definition →		10.94%	11.85%	14.51%	17.93%
Revenue per Share Full definition →		4.08	4.42	4.38	4.88
Operating CF per Share Full definition →		1.38	0.98	0.63	1.46
Capex per Share Full definition →		(0.09)	0.00	(0.07)	(0.03)
Free Cash Flow per Share Full definition →		1.29	0.98	0.57	1.42
Cash per Share Full definition →		5.59	5.35	5.00	6.36
Shareholders Equity per Share Full definition →		16.51	15.55	16.16	17.03
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		16.51	15.55	16.16	17.03
Free Cash Flow Full definition →		56.96	43.47	22.96	56.12
Working Capital Full definition →		455.67	427.38	406.17	493.20
Capital Expenditures Full definition →		(3.87)	(0.22)	(2.72)	(1.34)
Net Current Asset Value Full definition →		(7.61)	(23.83)	(39.68)	43.21
EV/EBIT Full definition →		35.32	77.62	53.20	66.21
Capex to Sales Full definition →		0.02	0.00	0.02	0.01
Price to Operating Income Full definition →		27.31	60.10	37.94	50.38
Other line items
Average Receivables Full definition →		107.96	118.69	115.19	123.39
Average Payables Full definition →		18.53	17.14	18.59	23.82
Average Inventory Full definition →		134.77	139.07	142.06	141.37
Average Assets Full definition →		1,409.63	1,409.22	1,397.60	1,390.62
Average Common Equity Full definition →		738.40	735.73	726.22	714.87

Fold the line items

Columns are period end dates

Stockrow Weekly